SubHero Banner
Text

2nd Quarter 2018

Key topics in this quarter’s edition include:

  • Galcanezumab: Prevention of migraines in adult patients
  • Lofexidine: To mitigate symptoms associated with opioid withdrawal and facilitate completion of opioid discontinuation treatment

Download PDF

Text